Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder

Translational Psychiatry

Volumn 7, Issue 1, 2017, Pages

  Charney, A W ^a   Ruderfer, D M ^a   Stahl, E A ^a   Moran, J L ^b   Chambert, K ^b   Belliveau, R A ^b   Forty, L ^c   Gordon Smith, K ^d   Di Florio, A ^c,e   Lee, P H ^b,f,g   Bromet, E J ^h   Buckley, P F ⁱ   Escamilla, M A ^j   Fanous, A H ^k,l   Fochtmann, L J ^h   Lehrer, D S ^m   Malaspina, D ⁿ   Marder, S R ^o   Morley, C P ^p   Nicolini, H ^q,r   Perkins, D O ^e   Rakofsky, J J ^s   Rapaport, M H ^s   Medeiros, H ^t   Sobell, J L ^t   Green, E K ^u   Backlund, L ^v   Bergen, S E ^b,v   Jureus A ^v   Schalling, M ^v   Lichtenstein, P ^v   Roussos, P ^a   Knowles, J A ^t   Jones, I ^c   Jones, L A ^d   Hultman, C M ^a,v   Perlis, R H ^g   Purcell, S M ^a   McCarroll, S A ^b,f   Pato, C N ^t   Pato, M T ^t   Craddock, N ^c   Landen M ^v,w   Smoller, J W ^b,f,g   Sklar, P ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF WORCESTER   (United Kingdom)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h STONY BROOK UNIVERSITY   (United States)

ⁱ MEDICAL COLLEGE OF GEORGIA   (United States)

^j TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^k VETERANS AFFAIRS MEDICAL CENTER   (United States)

^l GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m WRIGHT STATE UNIVERSITY   (United States)

ⁿ NEW YORK UNIVERSITY   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p STATE UNIVERSITY OF NEW YORK   (United States)

^q UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

^r Grupo Medico Carracci   (Mexico)

^s EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^u PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^v KAROLINSKA INSTITUTE   (Sweden)

^w UNIVERSITY OF GOTHENBURG   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADDUCIN; ADDUCIN 3; AMINOPEPTIDASE P; UNCLASSIFIED DRUG; ADD3 PROTEIN, HUMAN; AMINOPEPTIDASE; ANK3 PROTEIN, HUMAN; ANKYRIN; CACNA1C PROTEIN, HUMAN; CALCIUM CHANNEL L TYPE; CALMODULIN BINDING PROTEIN; NERVE PROTEIN; NUCLEAR PROTEIN; SYNE1 PROTEIN, HUMAN; X-PRO AMINOPEPTIDASE;

ARTICLE; BIPOLAR DISORDER; CHROMOSOME 10; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC CORRELATION; GENETIC HETEROGENEITY; GENOME-WIDE ASSOCIATION STUDY; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PHYLOGENY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CLASSIFICATION; GENETICS; GENOTYPE; PHENOTYPE; PSYCHOLOGY; PSYCHOSIS;

AMINOPEPTIDASES; ANKYRINS; BIPOLAR DISORDER; CALCIUM CHANNELS, L-TYPE; CALMODULIN-BINDING PROTEINS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 10; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS;

EID: 85020912677     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2016.242     Document Type: Article

References (56)

1. Kraepelin E. Manic-Depressive Insanity and Paranoia. E. & S. Livingstone, Edinburgh, 1921.
2. Leonhard K. Pathogenesis of manic-depressive disease. Der Nervenarzt 1957; 28: 271-272.
3. Dunner DL, Gershon ES, Goodwin FK. Heritable factors in the severity of affective illness. Biol Psychiatry 1976; 11: 31-42.
4. Fieve RR, Kumbaraci T, Dunner DL. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 1976; 133: 925-929.
5. Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011; 68: 241-251.
6. Ferrari AJ, Baxter AJ, Whiteford HA. A systematic review of the global distribution and availability of prevalence data for bipolar disorder. J Affect Disord 2011; 134: 1-13.
7. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50: 143-151.
8. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RMA, Petukhova M et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2007; 64: 543-552.
9. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003; 123C: 48-58.
10. Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Am Med Assoc 1982; 39: 1157-1167.
11. Heun R, Maier W. The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: results of a controlled family study. Acta Psychiatr Scand 1993; 87: 279-284.
12. Vandeleur CL, Merikangas KR, Strippoli MPF, Castelao E, Preisig M. Specificity of psychosis, mania and major depression in a contemporary family study. Mol Psychiatry 2013; 19: 209-213.
13. Merikangas KR, Cui L, Heaton L, Nakamura E, Roca C, Ding J et al. Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders. Mol Psychiatry 2014; 19: 214-219.
14. Kasanin J. The acute schizoaffective psychoses. Am J Psychiatry 1933; 90: 97-126.
15. Laursen TM, Labouriau R, Licht RW, Bertelsen A, Munk-Olsen T, Mortensen PB. Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study. Arch Gen Psychiatry 2005; 62: 841-848.
16. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234-239.
17. Ruderfer DM, Fanous AH, Ripke S, McQuillin A, Amdur RL et al. Schizophrenia Working Group of Psychiatric Genomics C Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry 2014; 19: 1017-1024.
18. Bertelsen A. Gottesman II. Schizoaffective psychoses: genetical clues to classification. Am J Med Genet 1995; 60: 7-11.
19. Cichon S, Mühleisen TW, Degenhardt FA, Mattheisen M, Miró X, Strohmaier J et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 2011; 88: 372-381.
20. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A et al. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007; 447: 661-678.
21. Scott LJ, Muglia P, Kong XQ, Guan W, Flickinger M, Upmanyu R et al. Genomewide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci USA 2009; 106: 7501-7506.
22. Sklar P, Smoller JW, Fan J, Ferreira MAR. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008; 13: 558-569.
23. Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W et al. Genomewide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 2009; 14: 755-763.
24. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977-983.
25. Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, Kassem L, Steele J et al. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 2009; 14: 487-491.
26. Chen DT, Jiang X, Akula N, Shugart YY, Wendland JR, Steele CJ et al. Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry 2013; 18: 195-205.
27. Muhleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F, Treutlein J et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun 2014; 5: 3339.
28. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
29. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC et al. International Schizophrenia Consortium Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
30. Lee SH, Ripke S, Neale BM, Faraone S V, Purcell SM, Perlis RH et al. Genetic relationship between five psychiatric disorders estimated from genomewide SNPs. Nat Genet 2013; 45: 984-994.
31. Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 2011; 88: 294-305.
32. Lee SH, DeCandia TR, Ripke S, Yang J, Sullivan PF, Goddard ME et al. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat Genet 2012; 44: 247-250.
33. Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS et al. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry 2010; 167: 1254-1263.
34. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371-1379.
35. Lee SH, Yang J, Goddard ME, Visscher PM, Wray NR. Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood. Bioinformatics 2012; 28: 2540-2542.
36. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kähler AK, Akterin S et al. Genomewide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013; 45: 1150-1159.
37. Barrett JC, Lee JC, Lees CW, Prescott NJ, Anderson CA et al. UK IBD Genetics Consortium Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009; 41: 1330-1334.
38. Bergen SE, O'Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S et al. Genomewide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 2012; 17: 880-886.
39. Green EK, Hamshere M, Forty L, Gordon-Smith K, Fraser C, Russell E et al. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder casecontrol sample. Mol Psychiatry 2013; 18: 1302-1307.
40. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990; 47: 589-593.
41. Pato MT, Sobell JL, Medeiros H, Abbott C, Sklar BM, Buckley PF et al. The Genomic Psychiatry Cohort: Partners in Discovery. Am J Med Genet B Neuropsychiatr Genet. 2013; 4: 306-312.
42. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991; 48: 764-770.
43. Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods 2013; 10: 5-6.
44. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 2012; 44: 955-959.
45. Schizophrenia Psychiatric Genome-Wide Association Study Consortium. Genomewide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976.
46. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium., Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013; 18: 497-511.
47. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999; 55: 997-1004.
48. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011; 88: 76-82.
49. Kruer MC, Jepperson T, Dutta S, Steiner RD, Cottenie E, Sanford L et al. Mutations in gamma adducin are associated with inherited cerebral palsy. Ann Neurol 2013; 74: 805-814.
50. Harbeck HT, Mentlein R. Aminopeptidase P from rat brain. Purification and action on bioactive peptides. Eur J Biochem 1991; 198: 451-458.
51. Xu K, Zhong G, Zhuang X. Actin, spectrin, and associated proteins form a periodic cytoskeletal structure in axons. Science 2013; 339: 452-456.
52. O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D et al. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 2011; 16: 286-292.
53. Vanhoof G, Goossens F, De Meester I, Hendriks D, Scharpe S. Proline motifs in peptides and their biological processing. FASEB J 1995; 9: 736-744.
54. Yoon SH, Bae YS, Mun MS, Park KY, Ye SK, Kim E et al. Developmental retardation, microcephaly, and peptiduria in mice without aminopeptidase P1. Biochem Biophys Res Commun 2012; 429: 204-209.
55. Ioannidis JPA, Thomas G, Daly MJ. Validating, augmenting and refining genomewide association signals. Nat Rev Genet 2009; 10: 318-329.
56. Parker G, Graham R, Hadzi-Pavlovic D, McCraw S, Hong M, Friend P. Differentiation of bipolar I and II disorders by examining for differences in severity of manic/ hypomanic symptoms and the presence or absence of psychosis during that phase. J Affect Disord 2013; 150: 941-947.